Plaquenil and Mircera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Plaquenil (hydroxychloroquine sulfate) and Mircera (methoxy polyethylene glycol-epoetin beta). Common drug interactions include dizziness among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Plaquenil and Mircera. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Plaquenil?

Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 91,018 Plaquenil users. Check the latest studies of Plaquenil.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.



On Jul, 11, 2026

14 people who take Plaquenil and Mircera together, and have interactions are studied.

Plaquenil and Mircera drug interactions.

What are the common drug interactions of Plaquenil and Mircera, by gender? *:

female:

  1. Dizziness
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Pericarditis lupus (inflammation of the pericardium with red ulcerations on the face)
  5. Urethral haemorrhage (urethral bleeding)
  6. Bacterial infection
  7. Cytomegalovirus infection
  8. Decreased appetite
  9. Hepatitis acute
  10. Renal impairment (severely reduced kidney function)

male:

  1. Death
  2. Genital herpes (herpes infection of genital)
  3. Pneumonia
  4. Urinary tract infection
  5. Vulvitis (inflammation of the vulva)

What are the common drug interactions of Plaquenil and Mircera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  3. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)

40-49:

n/a

50-59:

  1. Cataract (clouding of the lens inside the eye)
  2. Urethral haemorrhage (urethral bleeding)
  3. Mixed connective tissue disease (an autoimmune disease, in which the body's defence system attacks itself)
  4. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Anaemia macrocytic (a macrocytic class of anaemia)
  3. Hepatitis acute
  4. Renal impairment (severely reduced kidney function)
  5. Mastitis (inflammation of breast)
  6. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  7. Dizziness
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Pericarditis lupus (inflammation of the pericardium with red ulcerations on the face)

What are the existing conditions these people have? *

  1. Nephrogenic Anaemia (anaemia due to kidney disease): 5 people, 35.71%
  2. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 3 people, 21.43%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 14.29%
  4. Osteoporosis (bones weak and more likely to break): 2 people, 14.29%
  5. High Blood Pressure: 2 people, 14.29%
  6. Breast Infection: 2 people, 14.29%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Plaquenil and Mircera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Plaquenil and Mircera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Plaquenil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mircera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plaquenil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mircera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxychloroquine sulfate and methoxy polyethylene glycol-epoetin beta (the active ingredients of Plaquenil and Mircera, respectively), and Plaquenil and Mircera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: